These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6164757

  • 1. Postanoxic myoclonus. Treatment of a case with 5-hydroxytryptophane and a decarboxylase inhibitor.
    Beretta E, Regli F, de Crousaz G, Steck AJ.
    J Neurol; 1981; 225(1):57-62. PubMed ID: 6164757
    [Abstract] [Full Text] [Related]

  • 2. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
    Van Woert MH, Sethy VH.
    Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effects of serotonin precursors in postanoxic action myoclonus.
    De Léan J, Richardson JC, Hornykiewicz O.
    Neurology; 1976 Sep; 26(9):863-8. PubMed ID: 1084968
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
    Chadwick D, Hallett M, Harris R, Jenner P, Reynolds EH, Marsden CD.
    Brain; 1977 Sep; 100(3):455-87. PubMed ID: 412560
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serotonin and myoclonus.
    Van Woert MH, Jutkowitz R, Rosenbaum D, Bowers MB.
    Monogr Neural Sci; 1976 Sep; 3():71-80. PubMed ID: 790170
    [Abstract] [Full Text] [Related]

  • 11. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa.
    Thal L, Sharpless N, Wolfson L, Engel J, Katzman R.
    Trans Am Neurol Assoc; 1976 Sep; 101():48-52. PubMed ID: 1088459
    [No Abstract] [Full Text] [Related]

  • 12. Biochemistry and therapeutics of posthypoxic myoclonus.
    Van Woert MH, Rosenbaum D, Chung EY.
    Adv Neurol; 1986 Sep; 43():171-81. PubMed ID: 2418644
    [No Abstract] [Full Text] [Related]

  • 13. Pathological findings in a case of hypoxic myoclonus treated with 5-hydroxytryptophan and a decarboxylase inhibitor.
    De Léan J, Richardson JC, Rewcastle NB.
    Adv Neurol; 1986 Sep; 43():215-23. PubMed ID: 2418647
    [Abstract] [Full Text] [Related]

  • 14. Clinical, biochemical, and pharmacological observation in a patient with postasphyxic myoclonus: association to serotonin hyperactivity.
    Giménez-Roldán S, Mateo D, Muradas V, De Yebenes JG.
    Clin Neuropharmacol; 1988 Apr; 11(2):151-60. PubMed ID: 2454156
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Utilization of levo-5-hydroxytryptophan in post-anoxic myoclonus].
    Rascol A, Guiraud-Chaumeil B, Laboucarie J, Montastruc JL, El-Hage W.
    Therapie; 1978 Apr; 33(5):623-8. PubMed ID: 311085
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The clinical challenge of posthypoxic myoclonus.
    Frucht SJ.
    Adv Neurol; 2002 Apr; 89():85-8. PubMed ID: 11968475
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.